MedPath

Covered Self-expandable Metal Stents for Palliation of Malignant Biliary Strictures: Evaluation of a New Type of Stent

Not Applicable
Completed
Conditions
Malignant Biliary Strictures
Interventions
Device: Endoscopic retrograde cholangiography (ERC) (ComVi biliary stent)
Registration Number
NCT01457105
Lead Sponsor
Catholic University of the Sacred Heart
Brief Summary

self-expandable metal stents for palliation of malignant biliary strictures

Detailed Description

The ComVi biliary stent (Taewoong Medical Inc., Seoul, Korea), is a covered metallic stent with a expanded polytetrafluoroethylene (e-PTFE) membrane sandwiched between two wire layers and has a weaker axial force than other stents.

Patients with middle-distal malignant biliary stricture and with symptoms as jaundice, itching and pain.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Patients with malignant stenosis at the middle or lower third of the common bile duct inoperable and/or unresectable.
  • Patients without liver metastases and 6 months life expectancy
  • Patients at the first attempt of endoscopic biliary drainage.
  • Negative history for biliary tract surgery.
Exclusion Criteria
  • Patients with ampullary cancer.
  • Patients with hilar and/or intra-hepatic ducts malignancy.
  • Patients with haemobilia.
  • Patients with acute cholangitis at the time of stenting.
  • Patients with previous percutaneous, endoscopic or surgical biliary drainage.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ComVi biliary stentEndoscopic retrograde cholangiography (ERC) (ComVi biliary stent)-
Primary Outcome Measures
NameTimeMethod
patency and effectiveness of the ComVi stent in palliation of jaundice in patients with malignant biliary stricturestwo years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Catholic University

🇮🇹

Rome, RM, Italy

© Copyright 2025. All Rights Reserved by MedPath